Workshop: Accelerating Pathways from iPSCs to Patient Cure: Challenges, Solutions and Added Value of Strategic Partnerships
Hosted by Catalent
This workshop will address challenges in iPSC-derived cell therapy, including GMP line access, gene editing, scaling, and manufacturing. Panelists will share their strategies for overcoming these hurdles, and discuss how global partnerships can expedite the transition from innovation to patient treatment.
All #ATE24 workshops are FREE to attend, simply sign up via the form below.
Meet the Panelists:
- Frederic Cedrone, VP, Corporate Innovation, Catalent
- Boris Greber, Head of R&PD / iPS Cell Therapy, Catalent
- Terri Gaskell, Chief Technology Officer, Rinri Therapeutics
- Tiziana Rossetti, Principal, Sofinnova Partners
- Frederic Desdouits, Chief Executive Officer, TreeFrog Therapeutics
- Ricardo Baptista, Chief Technical Officer, Smartcella
Date & Time: 11th September 12.45 – 13.45
